Enterohemorrhagic Escherichia coli O157:H7 antigens produced in transgenic lettuce effective as an oral vaccine in mice
Theoretical and Applied Genetics · 2023-10 · 136 (10)
DOI: 10.1007/s00122-023-04460-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theoretical and Applied Genetics, online erschienen am 23.09.2023. Verfasst von Yun-Lin Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Plant Gene Engineering Center; Key Laboratory of South China Agricultural Plant Molecular Analysis and Genetic Improvement; Guangdong Provincial Key …. Hauptthemen laut MEDLINE: Vaccines, Enterohemorrhagic Escherichia coli. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, the National Key R&D Project, Key Project of Frontier Science Research of Chinese Academy of Sciences.
Abstract (Originalsprache)
KEY MESSAGE: Transgene with recombination sites to address biosafety concerns engineered into lettuce to produce EspB and γ-intimin C280 for oral vaccination against EHEC O157:H7. Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a food-borne pathogen where ruminant farm animals, mainly bovine, serve as reservoirs. Bovine vaccination has been used to prevent disease outbreaks, and the current method relies on vaccines subcutaneously injected three times per year. Since EHEC O157:H7 colonizes mucosal surfaces, an oral vaccine that produces an IgA response could be more convenient. Here, we report on oral vaccination against EHEC O157:H7 in mice orally gavaged with transgenic lettuce that produces EHEC O157:H7 antigens EspB and γ-intimin C280. Younger leaves accumulated a higher concentration of antigens; and in unexpanded leaves of 30-day-old T2 plants, EspB and γ-intimin C280 were up to 32 and 51 μg/g fresh weight, respectively. Mice orally gavaged with lettuce powders containing < 3 µg antigens for 6 days showed a mucosal immune response with reduced colonization of EHEC O157:H7. This suggests that the transgenic lettuce has potential to be used for bovine vaccination. To promote the biosafety of crop plants producing medically relevant proteins, recombination sites were built into our transgenic lines that would permit optional marker removal by Cre-lox recombination, as well as transgene deletion in pollen by CinH-RS2 recombination. The ability to upgrade the transgenic lettuce by stacking additional antigen genes or replacing older genes with newer versions would also be possible through the combined use of Bxb-att and Cre-lox recombination systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Plant Gene Engineering Center; Key Laboratory of South China Agricultural Plant Molecular Analysis and Genetic Improvement; Guangdong Provincial Key Laboratory of Applied Botany, South China Botanical Garden, Chinese Ac…
- Instituto de Agrobiotecnología y Biología Molecular (IABIMO) INTA-CONICET, Hurlingham, Argentina.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- the National Key R&D Project
- Key Project of Frontier Science Research of Chinese Academy of Sciences
- National Science and Technology Promotion Agency
Zitieren
APA
Su, Y. L., Larzábal, M., Song, H., Cheng, T., Wang, Y., Smith, L. Y., Cataldi, A. A., & Ow, D. W. (2023). Enterohemorrhagic Escherichia coli O157:H7 antigens produced in transgenic lettuce effective as an oral vaccine in mice. Theoretical and Applied Genetics, 136(10). https://doi.org/10.1007/s00122-023-04460-5
Vancouver
Su YL, Larzábal M, Song H, Cheng T, Wang Y, Smith LY, et al. Enterohemorrhagic Escherichia coli O157:H7 antigens produced in transgenic lettuce effective as an oral vaccine in mice. Theoretical and Applied Genetics. 2023;136(10). doi:10.1007/s00122-023-04460-5
BibTeX
@article{Su2023,
author = {Su, Yun-Lin and Larzábal, Mariano and Song, Huan and Cheng, Tianfang and Wang, Yufang and Smith, Libia Yael and Cataldi, Angel Adrian and Ow, David W},
title = {Enterohemorrhagic Escherichia coli O157:H7 antigens produced in transgenic lettuce effective as an oral vaccine in mice},
journal = {Theoretical and Applied Genetics},
year = {2023},
volume = {136},
number = {10},
doi = {10.1007/s00122-023-04460-5}
}
EUVIMED